Zynex (ZYXI) Competitors $8.36 +0.08 (+0.97%) As of 01/24/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZYXI vs. ESTA, FNA, EYE, BVS, AXGN, BFLY, CBLL, IRMD, AVNS, and SIBNShould you be buying Zynex stock or one of its competitors? The main competitors of Zynex include Establishment Labs (ESTA), Paragon 28 (FNA), National Vision (EYE), Bioventus (BVS), AxoGen (AXGN), Butterfly Network (BFLY), CeriBell (CBLL), Iradimed (IRMD), Avanos Medical (AVNS), and SI-BONE (SIBN). These companies are all part of the "medical equipment" industry. Zynex vs. Establishment Labs Paragon 28 National Vision Bioventus AxoGen Butterfly Network CeriBell Iradimed Avanos Medical SI-BONE Establishment Labs (NASDAQ:ESTA) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, community ranking, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment. Does the MarketBeat Community believe in ESTA or ZYXI? Establishment Labs received 88 more outperform votes than Zynex when rated by MarketBeat users. Likewise, 61.90% of users gave Establishment Labs an outperform vote while only 58.00% of users gave Zynex an outperform vote. CompanyUnderperformOutperformEstablishment LabsOutperform Votes11761.90% Underperform Votes7238.10% ZynexOutperform Votes2958.00% Underperform Votes2142.00% Does the media refer more to ESTA or ZYXI? In the previous week, Establishment Labs had 3 more articles in the media than Zynex. MarketBeat recorded 3 mentions for Establishment Labs and 0 mentions for Zynex. Establishment Labs' average media sentiment score of 1.17 beat Zynex's score of 0.00 indicating that Establishment Labs is being referred to more favorably in the media. Company Overall Sentiment Establishment Labs Positive Zynex Neutral Do insiders and institutionals have more ownership in ESTA or ZYXI? 72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 29.7% of Zynex shares are owned by institutional investors. 11.4% of Establishment Labs shares are owned by insiders. Comparatively, 52.1% of Zynex shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts rate ESTA or ZYXI? Establishment Labs presently has a consensus price target of $60.60, suggesting a potential upside of 84.25%. Zynex has a consensus price target of $14.00, suggesting a potential upside of 67.46%. Given Establishment Labs' higher possible upside, equities analysts clearly believe Establishment Labs is more favorable than Zynex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00Zynex 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation & earnings, ESTA or ZYXI? Zynex has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEstablishment Labs$165.15M5.58-$78.50M-$2.58-12.75Zynex$184.32M1.44$9.73M$0.1555.73 Which has more volatility and risk, ESTA or ZYXI? Establishment Labs has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Comparatively, Zynex has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500. Is ESTA or ZYXI more profitable? Zynex has a net margin of 2.49% compared to Establishment Labs' net margin of -46.13%. Zynex's return on equity of 13.05% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Establishment Labs-46.13% -184.55% -24.81% Zynex 2.49%13.05%3.78% SummaryEstablishment Labs beats Zynex on 10 of the 18 factors compared between the two stocks. Get Zynex News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZYXI vs. The Competition Export to ExcelMetricZynexElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$260.50M$3.54B$5.44B$9.27BDividend YieldN/A1.62%5.37%3.98%P/E Ratio55.7318.8688.9317.53Price / Sales1.4466.461,238.5381.52Price / Cash19.8839.3144.3737.67Price / Book6.153.955.084.74Net Income$9.73M$94.49M$117.95M$224.52M7 Day Performance8.85%0.75%3.11%1.43%1 Month Performance3.59%2.92%4.00%3.30%1 Year Performance-25.95%9.21%28.24%22.08% Zynex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZYXIZynex3.7162 of 5 stars$8.36+1.0%$14.00+67.5%-26.0%$260.50M$184.32M55.73770ESTAEstablishment Labs2.2683 of 5 stars$34.56-0.2%$60.60+75.3%-8.7%$967.68M$165.15M-13.40960FNAParagon 282.9551 of 5 stars$10.85+1.8%$15.60+43.7%-5.1%$908.61M$216.39M-14.67343,000EYENational Vision2.6619 of 5 stars$10.80+0.5%$13.50+25.0%-39.9%$850.50M$2.13B-54.0013,998Analyst ForecastGap UpHigh Trading VolumeBVSBioventus3.5297 of 5 stars$10.04-0.7%$15.00+49.4%+122.9%$814.75M$512.34M-16.461,200AXGNAxoGen0.8828 of 5 stars$18.09-1.8%$16.00-11.6%+90.7%$796.11M$180.86M-56.53450Analyst RevisionNews CoveragePositive NewsBFLYButterfly Network1.023 of 5 stars$3.67-5.4%$3.00-18.3%+285.6%$782.14M$65.90M-7.98460CBLLCeriBellN/A$21.04+4.4%$32.60+54.9%N/A$753.74M$60.04M0.00N/AIRMDIradimed4.6833 of 5 stars$59.17+1.4%$60.00+1.4%+40.0%$749.68M$65.56M40.53110AVNSAvanos Medical4.0335 of 5 stars$15.94-0.7%N/A-19.6%$732.60M$673.30M46.883,771News CoverageSIBNSI-BONE4.3549 of 5 stars$16.69-1.4%$23.00+37.8%-18.8%$699.98M$138.89M-18.14350Analyst Revision Related Companies and Tools Related Companies Establishment Labs Alternatives Paragon 28 Alternatives National Vision Alternatives Bioventus Alternatives AxoGen Alternatives Butterfly Network Alternatives CeriBell Alternatives Iradimed Alternatives Avanos Medical Alternatives SI-BONE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZYXI) was last updated on 1/26/2025 by MarketBeat.com Staff From Our PartnersNEW A.I. giant trading up to 84% less than MSFT – set to soar in 2025?I’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZYXI Stock Alerts